UNICANCER
- Country
- 🇧🇷Brazil
- Ownership
- Private
- Established
- 1964-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.unicancer.fr
Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax
- First Posted Date
- 2022-11-16
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 550
- Registration Number
- NCT05617963
- Locations
- 🇫🇷
Institut du Cancer Avignon-Provence, Avignon, France
🇫🇷Centre d'Oncologie du Pays Basque, Bayonne, France
🇫🇷CH de la côte Basque, Bayonne, France
Personalized Medicine for Advanced Biliary Cancer Patients
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 800
- Registration Number
- NCT05615818
- Locations
- 🇧🇪
Universitair Ziekenhuis Leuven, Leuven, Belgium
🇫🇷CHU Amiens Picardie, Amiens, France
🇫🇷CHU d'Angers, Angers, France
SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal Cancers
- Conditions
- Interventions
- First Posted Date
- 2022-10-17
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 420
- Registration Number
- NCT05582122
- Locations
- 🇫🇷
Institut de cancérologie de Lorraine, Vandœuvre-lès-Nancy, France
🇫🇷Clinique St Vincent- Réunion, Saint-Denis, La Réunion, France
🇫🇷ISC Avignon, Avignon, France
Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2022-09-23
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 96
- Registration Number
- NCT05552001
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, France
Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer
- First Posted Date
- 2022-07-27
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 118
- Registration Number
- NCT05476796
- Locations
- 🇫🇷
CHU d'Estaing, Clermont-Ferrand, France
🇫🇷Institut Andrée Dutreix - Clinique de Flandre, Coudekerque-Branche, France
🇫🇷Clinique de l'Europe, Amiens, France
TARGETed Therapy Drug MONITOring in DIGestive Oncology
- Conditions
- Interventions
- First Posted Date
- 2022-07-05
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 330
- Registration Number
- NCT05443087
- Locations
- 🇫🇷
CH d'Auxerre, Auxerre, France
🇫🇷Hôpital Beaujon APHP, Clichy, France
🇫🇷Institut Jean Godinot, Reims, France
Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk
- First Posted Date
- 2022-03-28
- Last Posted Date
- 2024-02-05
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 696
- Registration Number
- NCT05297617
- Locations
- 🇫🇷
Centre Hospitalier Universitaire de Limoges, Limoges, France
🇫🇷Institute Gustave Roussy, Villejuif, France
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients With Metastatic Cancer in Response After 6 Months of Standard IO
- Conditions
- Interventions
- First Posted Date
- 2021-10-14
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 646
- Registration Number
- NCT05078047
- Locations
- 🇫🇷
CHU Bordeaux - Hôpial Saint André, Bordeaux, France
🇫🇷CH Boulogne sur Mer, Boulogne-sur-Mer, France
🇫🇷GH Mutualiste de Grenoble, Grenoble, France
Patient's Choice in the Reduction of Their Treatment in Women Over 65 Year With Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2021-09-27
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 104
- Registration Number
- NCT05058196
- Locations
- 🇫🇷
Institut Paoli-Calmettes, Marseille, France
Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2021-09-13
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 53
- Registration Number
- NCT05041842
- Locations
- 🇫🇷
Institut de Cancérologie de l'Ouest - Site Paul Papin, Angers, France
🇫🇷Centre Francois Baclesse, Caen, France
🇫🇷Centre Georges François Leclerc, Dijon, France